{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:22:55Z","timestamp":1793726575460,"version":"4.6.1"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007569","name":"Carl Zeiss Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008662","name":"Joachim Herz Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["514006196"],"award-info":[{"award-number":["514006196"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["316213987"],"award-info":[{"award-number":["316213987"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC 1278"],"award-info":[{"award-number":["CRC 1278"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["C06"],"award-info":[{"award-number":["C06"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jconrel.2026.115023","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:20:00Z","timestamp":1778811600000},"page":"115023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Innovative lipid nanoparticle formulations: Bridging the gap toward decentralized personalized gene therapies"],"prefix":"10.1016","volume":"395","author":[{"given":"Michael","family":"Streiber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich S.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Traeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115023_bb0005","doi-asserted-by":"crossref","first-page":"2100109","DOI":"10.1002\/anbr.202100109","article-title":"Lipid nanoparticles for drug delivery","volume":"2","author":"Xu","year":"2022","journal-title":"Adv. Nanobiomed. Res."},{"key":"10.1016\/j.jconrel.2026.115023_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400938","article-title":"Advances in lipid nanoparticle-based disease treatment","volume":"20","author":"Zhou","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jconrel.2026.115023_bb0015","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115023_bb0025","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics - developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115023_bb0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115023_bb0035","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115023_bb0040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115023_bb0045","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.115023_bb0050","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307798120","article-title":"Recent advances in nanoparticulate RNA delivery systems","volume":"121","author":"Witten","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115023_bb0055","first-page":"1722","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Rim","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115023_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41573-019-0049-9","article-title":"Therapies for rare diseases: therapeutic modalities, progress and challenges ahead","volume":"19","author":"Tambuyzer","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115023_bb0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jgg.2023.08.001","article-title":"Gene therapy for monogenic disorders: challenges, strategies, and perspectives","volume":"51","author":"Zhang","year":"2024","journal-title":"J. Genet. Genomics"},{"key":"10.1016\/j.jconrel.2026.115023_bb0070","article-title":"The landscape for rare diseases in 2024","volume":"12","author":"H. The Lancet Global","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jconrel.2026.115023_bb0075","doi-asserted-by":"crossref","first-page":"1553590","DOI":"10.3389\/fgeed.2025.1553590","article-title":"CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders","volume":"7","author":"Cabr\u00e9-Romans","year":"2025","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.jconrel.2026.115023_bb0080","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjd.21686","article-title":"The challenges of clinical trials in rare diseases","volume":"187","author":"Mellerio","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115023_bb0090","doi-asserted-by":"crossref","first-page":"1629021","DOI":"10.3389\/fsci.2025.1629021","article-title":"The long-awaited solution for personalized medicine","volume":"3","author":"Khorkova","year":"2025","journal-title":"Front. Sci."},{"key":"10.1016\/j.jconrel.2026.115023_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24606","article-title":"Lipid nanoparticles: the game-changer in CRISPR-Cas9 genome editing","volume":"10","author":"Mohammadian Farsani","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jconrel.2026.115023_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fsci.2025.1458636","article-title":"NANOSPRESSO: toward personalized, locally produced nucleic acid nanomedicines","volume":"3","author":"Estap\u00e9 Senti","year":"2025","journal-title":"Front. Sci."},{"key":"10.1016\/j.jconrel.2026.115023_bb0105","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJMoa1813279","article-title":"Patient-customized oligonucleotide therapy for a rare genetic disease","volume":"381","author":"Kim","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115023_bb0110","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ajhg.2025.02.017","article-title":"Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments","volume":"112","author":"Cheerie","year":"2025","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jconrel.2026.115023_bb0115","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/acs.molpharmaceut.1c00916","article-title":"Lipid-nanoparticle-based delivery of CRISPR\/Cas9 genome-editing components","volume":"19","author":"Kazemian","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115023_bb0120","doi-asserted-by":"crossref","first-page":"18717","DOI":"10.1038\/s41598-025-03671-8","article-title":"Lipid nanoparticle delivery of the CRISPR\/Cas9 system directly into the mitochondria of cells carrying m.7778G>T mutation in MtDNA (mt-Atp8)","volume":"15","author":"Norota","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115023_bb0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115023_bb0130","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-specific in vivo gene editing to treat a rare genetic disease, N","volume":"392","author":"Musunuru","year":"2025","journal-title":"Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115023_bb0135","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.2217\/nnm-2016-0275","article-title":"Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma","volume":"11","author":"Grabbe","year":"2016","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2026.115023_bb0140","article-title":"Preclinical advances in LNP-CRISPR therapeutics for solid tumor treatment","volume":"13","author":"Wang","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115023_bb0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12943-023-01738-6","article-title":"Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.115023_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115023_bb0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc3950","article-title":"Applications of the CRISPR-Cas9 system in cancer biology","volume":"15","author":"Sanchez-Rivera","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115023_bb0160","doi-asserted-by":"crossref","first-page":"e2443198","DOI":"10.1001\/jamanetworkopen.2024.43198","article-title":"Global disparities of cancer and its projected burden in 2050","volume":"7","author":"Bizuayehu","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jconrel.2026.115023_bb0165","doi-asserted-by":"crossref","first-page":"1382190","DOI":"10.3389\/fmolb.2024.1382190","article-title":"Advances and challenges in gene therapy strategies for pediatric cancer: a comprehensive update","volume":"11","author":"Moaveni","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jconrel.2026.115023_bb0170","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: An overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Mater. Au"},{"key":"10.1016\/j.jconrel.2026.115023_bb0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303567120","article-title":"Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines","volume":"120","author":"Shepherd","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115023_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101463","article-title":"Lipid nanoparticles: composition, formulation, and application","volume":"33","author":"Xu","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2026.115023_bb0185","doi-asserted-by":"crossref","first-page":"23959","DOI":"10.1039\/D0NR06816K","article-title":"Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles","volume":"12","author":"Kulkarni","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115023_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115023_bb0195","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0022-2836(64)80115-7","article-title":"Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope","volume":"8","author":"Bangham","year":"1964","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0200","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles-from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115023_bb0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-5173(01)00721-9","article-title":"Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics","volume":"223","author":"Berger","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115023_bb0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.scp.2017.07.002","article-title":"Lipid nanoparticles: different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery","volume":"6","author":"Ganesan","year":"2017","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.jconrel.2026.115023_bb0215","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1208\/s12249-008-9097-x","article-title":"Conventional and dense gas techniques for the production of liposomes: a review","volume":"9","author":"Meure","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2026.115023_bb0220","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.75.9.4194","article-title":"Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation","volume":"75","author":"Szoka","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115023_bb0225","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1104\/pp.68.5.1027","article-title":"Transfer of liposome-sequestering plasmid DNA into daucus carota protoplasts","volume":"68","author":"Uchimiya","year":"1981","journal-title":"Plant Physiol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0230","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1021\/acs.jpcb.5b02891","article-title":"Microfluidic mixing: a general method for encapsulating macromolecules in lipid nanoparticle systems","volume":"119","author":"Leung","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jconrel.2026.115023_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120826","article-title":"Microfluidic formulation of nanoparticles for biomedical applications","volume":"274","author":"Shepherd","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115023_bb0240","doi-asserted-by":"crossref","first-page":"2106580","DOI":"10.1002\/smll.202106580","article-title":"Microfluidic nanoparticles for drug delivery","volume":"18","author":"Liu","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115023_bb0245","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jcis.2020.11.070","article-title":"High throughput acoustic microfluidic mixer controls self-assembly of protein nanoparticles with tuneable sizes","volume":"585","author":"Pourabed","year":"2021","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2026.115023_bb0250","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1080\/17425247.2016.1193151","article-title":"Microfluidic nanoprecipitation systems for preparing pure drug or polymeric drug loaded nanoparticles: an overview","volume":"13","author":"Ding","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115023_bb0255","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/mi7120225","article-title":"Polymer microfluidics: simple, low-cost fabrication process bridging academic lab research to commercialized production","volume":"7","author":"Tsao","year":"2016","journal-title":"Micromachines (Basel)"},{"key":"10.1016\/j.jconrel.2026.115023_bb0260","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/j.apsb.2023.01.018","article-title":"Microfluidics for nano-drug delivery systems: from fundamentals to industrialization","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115023_bb0265","first-page":"183","article-title":"Delivering 3 billion doses of Comirnaty in 2021","volume":"41","author":"Warne","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0270","doi-asserted-by":"crossref","DOI":"10.1063\/5.0002125","article-title":"Flow physics and mixing quality in a confined impinging jet mixer","volume":"10","author":"Hao","year":"2020","journal-title":"AIP Adv."},{"key":"10.1016\/j.jconrel.2026.115023_bb0275","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.apsb.2018.11.001","article-title":"Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles","volume":"9","author":"Tao","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115023_bb0280","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1080\/10717544.2022.2108523","article-title":"Single pot organic solvent-free thermocycling technology for siRNA-ionizable LNPs: a proof-of-concept approach for alternative to microfluidics","volume":"29","author":"De","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115023_bb0285","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1021\/acs.nanolett.4c06643","article-title":"A post-encapsulation method for the preparation of mRNA-LNPs via the nucleic acid-bridged fusion of mRNA-free LNPs","volume":"25","author":"Tanaka","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115023_bb0290","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1038\/s41598-022-12100-z","article-title":"DoE-derived continuous and robust process for manufacturing of pharmaceutical-grade wide-range LNPs for RNA-vaccine\/drug delivery","volume":"12","author":"Nag","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115023_bb0295","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1039\/D2LC00463A","article-title":"Liposome manufacturing under continuous flow conditions: towards a fully integrated set-up with in-line control of critical quality attributes","volume":"23","author":"Sheybanifard","year":"2023","journal-title":"Lab Chip"},{"key":"10.1016\/j.jconrel.2026.115023_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107183","article-title":"Advancing continuous encapsulation and purification of mRNA vaccines and therapeutics","volume":"212","author":"Nourafkan","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115023_bb0305","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jps.24324","article-title":"Regulatory and quality considerations for continuous manufacturing May 20\u201321, 2014 continuous manufacturing symposium","volume":"104","author":"Allison","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115023_bb0310","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cep.2010.08.010","article-title":"Future manufacturing approaches in the chemical and pharmaceutical industry","volume":"49","author":"Buchholz","year":"2010","journal-title":"Chem. Eng. Process."},{"key":"10.1016\/j.jconrel.2026.115023_bb0315","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1080\/17435889.2025.2500911","article-title":"How could the affordable, reliable and continuous production of lipid nanoparticles revolutionize healthcare?","volume":"20","author":"Burroughs","year":"2025","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115023_bb0320","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s11606-020-05805-2","article-title":"Orphan drugs offer larger health gains but less favorable cost-effectiveness than non-orphan drugs","volume":"35","author":"Chambers","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jconrel.2026.115023_bb0325","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nbt0315-217","article-title":"$1-million price tag set for Glybera gene therapy","volume":"33","author":"Morrison","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0330","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41434-024-00452-2","article-title":"Towards ethical drug pricing: the european orphan genomic therapies fund","volume":"31","author":"Risse","year":"2024","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2026.115023_bb0335","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nbt0617-491","article-title":"After Glybera's withdrawal, what's next for gene therapy?","volume":"35","author":"Senior","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0340","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jval.2022.01.006","article-title":"The net benefit of personalized medicine: a systematic literature review and regression analysis","volume":"25","author":"Vellekoop","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.jconrel.2026.115023_bb0345","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/jpm7040012","article-title":"Personalized nanomedicine: a revolution at the nanoscale","volume":"7","author":"Fornaguera","year":"2017","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jconrel.2026.115023_bb0350","doi-asserted-by":"crossref","unstructured":"The future of medicine, Nat. Med. 2025, 31, 1\u20131.","DOI":"10.1038\/s41591-024-03464-y"},{"key":"10.1016\/j.jconrel.2026.115023_bb0355","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12967-020-02316-w","article-title":"How personalised medicine will transform healthcare by 2030: the ICPerMed vision","volume":"18","author":"Vicente","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115023_bb0360","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/17425247.2022.2093857","article-title":"The sustainability of emerging technologies for use in pharmaceutical manufacturing","volume":"19","author":"Weaver","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115023_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115190","article-title":"mRNA delivery systems for cancer immunotherapy: lipid nanoparticles and beyond","volume":"206","author":"Estap\u00e9 Senti","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115023_bb0370","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","article-title":"An ionizable lipid toolbox for RNA delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115023_bb0375","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1016\/j.biomaterials.2010.05.027","article-title":"The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation","volume":"31","author":"Kedmi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115023_bb0380","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115023_bb0385","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41557-024-01557-2","article-title":"Fast and facile synthesis of amidine-incorporated degradable lipids for versatile mRNA delivery in vivo","volume":"16","author":"Han","year":"2024","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jconrel.2026.115023_bb0390","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/mt.2013.124","article-title":"Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics","volume":"21","author":"Maier","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115023_bb0395","article-title":"Rational design and modular synthesis of biodegradable ionizable lipids via the Passerini reaction for mRNA delivery","volume":"122","author":"Xu","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115023_bb0400","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41565-025-01925-0","article-title":"Better the devil you know than the devil you don\u2019t - PEG challenges in nanomedicine","volume":"20","author":"Dobrovolskaia","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0405","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1039\/D3NH00198A","article-title":"Anti-PEG antibodies enriched in the protein corona of PEGylated nanocarriers impact the cell uptake","volume":"8","author":"Deuker","year":"2023","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.jconrel.2026.115023_bb0410","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115023_bb0415","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ymthe.2021.01.030","article-title":"Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines","volume":"29","author":"Moghimi","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115023_bb0420","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115023_bb0425","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115023_bb0430","first-page":"86","article-title":"Engineering LNPs with polysarcosine lipids for mRNA delivery","volume":"37","author":"Kang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115023_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082068","article-title":"Polysarcosine-functionalized mRNA lipid nanoparticles tailored for immunotherapy","volume":"15","author":"Wilhelmy","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115023_bb0440","doi-asserted-by":"crossref","first-page":"32567","DOI":"10.1021\/jacs.4c11347","article-title":"Zwitterionic polymer-functionalized lipid nanoparticles for the nebulized delivery of mRNA","volume":"146","author":"Jiang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115023_bb0445","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1021\/acs.biomac.3c00649","article-title":"Zwitterionic polymer-decorated lipid nanoparticles for mRNA delivery in mammalian cells","volume":"24","author":"Khunsuk","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115023_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/marc.202500428","article-title":"Polyglycerol-based lpids: a next-generation alternative to PEG in lipid nanoparticles for advanced drug delivery systems","author":"Ensminger","year":"2025","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2026.115023_bb0455","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202411354","article-title":"Poly(2-ethyl-2-oxazoline) (POx) as poly(ethylene glycol) (PEG)-lipid substitute for lipid nanoparticle formulations","volume":"21","author":"Holick","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115023_bb0460","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304033","article-title":"Substituting poly(ethylene glycol) lipids with poly(2-ethyl-2-oxazoline) lipids improves lipid nanoparticle repeat dosing","volume":"13","author":"Sanchez","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115023_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202404972","article-title":"Facile generation of heterotelechelic poly(2-oxazoline)s towards accelerated exploration of poly(2-oxazoline)-based nanomedicine","volume":"63","author":"Van Guyse","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115023_bb0470","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1016\/j.biomaterials.2014.02.029","article-title":"On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s","volume":"35","author":"Ulbricht","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115023_bb0475","article-title":"Tailoring cationic poly(2-oxazoline)s: minimizing toxicity and immunogenic response for biological applications","volume":"44","author":"Streiber","year":"2025","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.jconrel.2026.115023_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110219","article-title":"Predicting the environmental emissions arising from conventional and nanotechnology-related pharmaceutical drug products","volume":"192","author":"Jung","year":"2021","journal-title":"Environ. Res."},{"key":"10.1016\/j.jconrel.2026.115023_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/nano11123324","article-title":"A content review of life cycle assessment of nanomaterials: current practices, challenges, and future prospects","volume":"11","author":"Nizam","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2026.115023_bb0490","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.impact.2017.12.003","article-title":"Life cycle assessment of manufactured nanomaterials: where are we?","volume":"10","author":"Salieri","year":"2018","journal-title":"NanoImpact"},{"key":"10.1016\/j.jconrel.2026.115023_bb0495","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/S2542-5196(25)00028-2","article-title":"The greenhouse gas emissions of pharmaceutical consumption and production: an input\u2013output analysis over time and across global supply chains","volume":"9","author":"Hagenaars","year":"2025","journal-title":"Lancet Planet. Health"},{"key":"10.1016\/j.jconrel.2026.115023_bb0500","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/ckaa165.843","article-title":"Health care\u2019s climate footprint: the health sector contribution and opportunities for action","volume":"30","author":"Karliner","year":"2020","journal-title":"Eur. J. Pub. Health"},{"key":"10.1016\/j.jconrel.2026.115023_bb0505","article-title":"Exploring the landscape of lipid nanoparticles (LNPs): a comprehensive review of LNPs types and biological sources of lipids","volume":"8","author":"Alfutaimani","year":"2024","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.jconrel.2026.115023_bb0510","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1007\/s11101-025-10086-w","article-title":"An alternative source of medicines: pharmaceutical utilization of animal-derived metabolites","volume":"24","author":"Renda","year":"2025","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.jconrel.2026.115023_bb0515","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/adsc.202300103","article-title":"Short and scalable synthesis of plant-based cholesterol in GMP grade","volume":"365","author":"Munt","year":"2023","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.jconrel.2026.115023_bb0520","article-title":"Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA","volume":"11","author":"Patel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115023_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112357","article-title":"Stability study of mRNA-lipid nanoparticles exposed to various conditions based on the evaluation between physicochemical properties and their relation with protein expression ability","volume":"14","author":"Kamiya","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115023_bb0530","article-title":"Trends in uptake and impact of thermostable vaccines in Africa","volume":"13","author":"Kitui","year":"2025","journal-title":"Ther. Adv. Vaccines Immunother."},{"key":"10.1016\/j.jconrel.2026.115023_bb0535","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/14760584.2023.2273901","article-title":"Challenges in vaccine transport: can we deliver without the cold chain?","volume":"22","author":"Bajrovic","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2026.115023_bb0540","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.3390\/ijerph18147425","article-title":"The ecological footprint of COVID-19 mRNA vaccines: estimating greenhouse gas emissions in Germany","volume":"18","author":"Kurzweil","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jconrel.2026.115023_bb0545","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/systems12070264","article-title":"Cold chain logistics and joint distribution: a review of fresh logistics modes","volume":"12","author":"Shi","year":"2024","journal-title":"Systems"},{"key":"10.1016\/j.jconrel.2026.115023_bb0550","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/IJN.S123062","article-title":"Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization","volume":"12","author":"Ball","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115023_bb0555","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s42003-024-06235-0","article-title":"Overcoming thermostability challenges in mRNA\u2013lipid nanoparticle systems with piperidine-based ionizable lipids","volume":"7","author":"Hashiba","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10668-012-9365-5","article-title":"A system view of solvent selection in the pharmaceutical industry: towards a sustainable choice","volume":"15","author":"Perez-Vega","year":"2013","journal-title":"Environ. Dev. Sustain."},{"key":"10.1016\/j.jconrel.2026.115023_bb0565","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1039\/c003666h","article-title":"LCA approach to the analysis of solvent waste issues in the pharmaceutical industry","volume":"12","author":"Raymond","year":"2010","journal-title":"Green Chem."},{"key":"10.1016\/j.jconrel.2026.115023_bb0570","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1039\/B918763B","article-title":"Green chemistry: principles and practice","volume":"39","author":"Anastas","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.115023_bb0575","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/acs.oprd.1c00216","article-title":"Green chemistry: a framework for a sustainable future","volume":"25","author":"Ganesh","year":"2021","journal-title":"Org. Process. Res. Dev."},{"key":"10.1016\/j.jconrel.2026.115023_bb0580","doi-asserted-by":"crossref","first-page":"6564","DOI":"10.1039\/C6GC02440H","article-title":"Q-SA\u221aESS: a methodology to help solvent selection for pharmaceutical manufacture at the early process development stage","volume":"18","author":"Isoni","year":"2016","journal-title":"Green Chem."},{"key":"10.1016\/j.jconrel.2026.115023_bb0585","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0006-3495(01)76202-9","article-title":"Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes","volume":"80","author":"Maurer","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2026.115023_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101518","article-title":"Rational design of lipid nanoparticles for enabling gene therapies","volume":"33","author":"Brimacombe","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2026.115023_bb0595","doi-asserted-by":"crossref","first-page":"1700375","DOI":"10.1002\/smtd.201700375","article-title":"State-of-the-art design and rapid-mixing production techniques of lipid nanoparticles for nucleic acid delivery","volume":"2","author":"Evers","year":"2018","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2026.115023_bb0600","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1002\/anie.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"51","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115023_bb0605","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0610","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1039\/D1BM00866H","article-title":"Boosting ionizable lipid nanoparticle-mediated in vivo mRNA delivery through optimization of lipid amine-head groups","volume":"9","author":"Ding","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115023_bb0615","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ymthe.2019.05.002","article-title":"Lipidoid-siRNA nanoparticle-mediated IL-1\u03b2 gene silencing for systemic arthritis therapy in a mouse model","volume":"27","author":"Song","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115023_bb0620","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/pharmaceutics17080950","article-title":"Formulation-driven optimization of PEG-lipid content in lipid nanoparticles for enhanced mRNA delivery in vitro and in vivo","volume":"17","author":"Liu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115023_bb0625","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.actbio.2024.02.004","article-title":"Incorporation of poly(\u03b3-glutamic acid) in lipid nanoparticles for enhanced mRNA delivery efficiency in vitro and in vivo","volume":"177","author":"Zhang","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115023_bb0630","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202400815","article-title":"Preformed vesicle approach to LNP manufacturing enhances retinal mRNA delivery","volume":"20","author":"Eygeris","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115023_bb0635","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1007\/s13346-025-01866-0","article-title":"Post-encapsulation methods for the preparation of mRNA-LNPs","volume":"15","author":"Duffr\u00e8ne","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115023_bb0640","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501788","article-title":"Admixing of mRNA with pre-formed lipid nanoparticles containing a slightly-cationic ionizable lipid allows for efficient mRNA transfection in vitro and in vivo","volume":"14","author":"Wang","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115023_bb0645","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/acsnano.2c10501","article-title":"Ready-to-use-type lyophilized lipid nanoparticle formulation for the postencapsulation of messenger RNA","volume":"17","author":"Tanaka","year":"2023","journal-title":"ACS Nano"},{"issue":"27","key":"10.1016\/j.jconrel.2026.115023_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202511489","article-title":"Extrahepatic gene editing in vivo using organic solvent-free lipid nanoparticles","volume":"22","author":"Streiber","year":"2026","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115023_bb0655","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115023_bb0660","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2020.03.006","article-title":"Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E\/low density lipoprotein receptor and the N-acetyl-d-galactosamine\/asialoglycoprotein receptor pathway","volume":"322","author":"Sato","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115023_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091886","article-title":"Review on the scale-up methods for the preparation of solid lipid nanoparticles","volume":"14","author":"Khairnar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115023_bb0670","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16121521","article-title":"Effect of lipid nanoparticle physico-chemical properties and composition on their interaction with the immune system","volume":"16","author":"Catenacci","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115023_bb0675","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s43586-023-00258-3","article-title":"Best practices for characterizing RNA lipid nanoparticles","volume":"3","author":"Khan","year":"2023","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.jconrel.2026.115023_bb0680","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Zhang","year":"2023","journal-title":"npj Vaccin."},{"key":"10.1016\/j.jconrel.2026.115023_bb0685","first-page":"923","article-title":"Construction of stable anionic liposome-plasmid particles using the heating method: a preliminary investigation","volume":"7","author":"Mozafari","year":"2002","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.jconrel.2026.115023_bb0690","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jbiotec.2007.02.005","article-title":"Preparation of liposomal gene therapy vectors by a scalable method without using volatile solvents or detergents","volume":"129","author":"Mortazavi","year":"2007","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0695","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/02652049809006835","article-title":"Mechanism of calcium ion induced multilamellar vesicle-DNA interaction","volume":"15","author":"Mozafari","year":"1998","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2026.115023_bb0700","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/10717549809031389","article-title":"Formation of supramolecular structures by negatively charged liposomes in the presence of nucleic acids and divalent cations","volume":"5","author":"Mozafari","year":"1998","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115023_bb0705","article-title":"Encapsulation of protein\/DNA complexes into unilamellar liposomes via annexin-mediated membrane recruitment and sonication","volume":"5","author":"Burger","year":"2025","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.jconrel.2026.115023_bb0710","doi-asserted-by":"crossref","first-page":"8594","DOI":"10.1021\/acsnano.0c02946","article-title":"Nanopore and nanoparticle formation with lipids undergoing polymorphic phase transitions","volume":"14","author":"Cholakova","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115023_bb0715","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature16189","article-title":"Self-shaping of oil droplets via the formation of intermediate rotator phases upon cooling","volume":"528","author":"Denkov","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115023_bb0720","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15012","article-title":"Efficient self-emulsification via cooling-heating cycles","volume":"8","author":"Tcholakova","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115023_bb0725","doi-asserted-by":"crossref","first-page":"12155","DOI":"10.1021\/acs.langmuir.7b02048","article-title":"Mechanisms and control of self-emulsification upon freezing and melting of dispersed alkane drops","volume":"33","author":"Valkova","year":"2017","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2026.115023_bb0730","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.xphs.2023.11.023","article-title":"Factors affecting stability of RNA \u2013 temperature, length, concentration, pH, and buffering species","volume":"113","author":"Chheda","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115023_bb0735","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3390\/pharmaceutics15122786","article-title":"Stability of naked nucleic acids under physical treatment and powder formation: suitability for development as dry powder formulations for inhalation","volume":"15","author":"Okuda","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115023_bb0740","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s42004-025-01699-5","article-title":"Spotlighting the criticality of lipid quality control through a mechanistic investigation of mRNA activity loss in lipid nanoparticles","volume":"8","author":"Kang","year":"2025","journal-title":"Commun. Chem."},{"key":"10.1016\/j.jconrel.2026.115023_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.913297","article-title":"Impact of heating temperature and fatty acid type on the formation of lipid oxidation products during thermal processing","volume":"9","author":"Zhuang","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.jconrel.2026.115023_bb0750","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41434-023-00390-5","article-title":"Successes and challenges in clinical gene therapy","volume":"30","author":"Kohn","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2026.115023_bb0755","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-022-00104-y","article-title":"Nanodelivery of nucleic acids","volume":"2","author":"Mendes","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.jconrel.2026.115023_bb0760","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3390\/pharmaceutics16111366","article-title":"The impact of COVID-19 on RNA therapeutics: a surge in lipid nanoparticles and alternative delivery systems","volume":"16","author":"Parvin","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115023_bb0765","doi-asserted-by":"crossref","first-page":"0370","DOI":"10.34133\/research.0370","article-title":"Unlocking the therapeutic applicability of LNP-mRNA: chemistry, formulation, and clinical strategies","volume":"7","author":"Huang","year":"2024","journal-title":"Research"},{"key":"10.1016\/j.jconrel.2026.115023_bb0770","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1039\/b821183c","article-title":"Interfacial tension governs the formation of self-organized honeycomb-patterned polymer films","volume":"5","author":"Fukuhira","year":"2009","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2026.115023_bb0775","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400199","article-title":"Chemical design strategy of ionizable lipids for in vivo mRNA delivery","volume":"19","author":"He","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jconrel.2026.115023_bb0780","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.fluid.2018.06.019","article-title":"Accurate modeling of multiphase behavior of aqueous systems. I. Alkanes, alkenes, cycloalkanes, alcohols, aromatics","volume":"473","author":"NguyenHuynh","year":"2018","journal-title":"Fluid Phase Equilib."},{"key":"10.1016\/j.jconrel.2026.115023_bb0785","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1039\/D2SM00403H","article-title":"Effects of the structure of lipid-based agents in their complexation with a single stranded mRNA fragment: a computational study","volume":"18","author":"Rissanou","year":"2022","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2026.115023_bb0790","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202416331","article-title":"Enhancing specificity, precision, accessibility, flexibility, and safety to overcome traditional CRISPR\/Cas editing challenges and shape future innovations","volume":"12","author":"Alariqi","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115023_bb0795","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molcel.2016.07.004","article-title":"Methods for optimizing CRISPR-Cas9 genome editing specificity","volume":"63","author":"Tycko","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2026.115023_bb0800","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.xphs.2022.12.026","article-title":"Effect of cholesterol content of lipid composition in mRNA-LNPs on the protein expression in the injected site and liver after local administration in mice","volume":"112","author":"Kawaguchi","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115023_bb0805","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.115023_bb0810","doi-asserted-by":"crossref","DOI":"10.1038\/s41596-025-01330-w","article-title":"Preparation of targeted lipid nanoparticles for precision nucleic acid delivery","author":"Geisler","year":"2026","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2026.115023_bb0815","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1038\/ncomms6565","article-title":"Cell type-specific delivery of short interfering RNAs by dye-functionalised theranostic nanoparticles","volume":"5","author":"Press","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115023_bb0820","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/s41467-024-50093-7","article-title":"Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","volume":"15","author":"Su","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115023_bb0825","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-026-01615-9","article-title":"\u2018Tripod-like\u2019 lung-targeting (LuT) lipids for highly efficient and selective LNPs for gene delivery and editing","author":"Tian","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115023_bb0830","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"issue":"13","key":"10.1016\/j.jconrel.2026.115023_bb0835","doi-asserted-by":"crossref","first-page":"14137","DOI":"10.1021\/jacs.6c00080","article-title":"Liver-detargeted aromatic bioreducible mRNA lipid nanoparticles confer lymph node tropism and robust antigen-specific immunity","volume":"148","author":"Yamagata","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115023_bb0840","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.ade6967","article-title":"In vivo hematopoietic stem cell modification by mRNA delivery","volume":"381","author":"Breda","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115023_bb0845","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2018.10.015","article-title":"PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake","volume":"291","author":"Parhiz","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115023_bb0850","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","article-title":"In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles","volume":"23","author":"Shi","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115023_bb0855","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114436","article-title":"Targeted delivery of a phosphoinositide 3-kinase \u03b3 inhibitor to restore organ function in sepsis","volume":"13","author":"Press","year":"2021","journal-title":"EMBO. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115023_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.mattod.2025.12.034","article-title":"A material toolbox for engineering targeted lipid nanoparticles for RNA therapies","volume":"93","author":"Yoo","year":"2026","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2026.115023_bb0865","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202401632","article-title":"Lipid nanoparticles for delivery of CRISPR gene editing components","volume":"10","author":"Wu","year":"2026","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2026.115023_bb0870","first-page":"562","article-title":"A cuttlefish ink nanoparticle-reinforced biopolymer hydrogel with robust adhesive and immunomodulatory features for treating oral ulcers in diabetes","volume":"39","author":"Xiang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115023_bb0875","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/17425247.2023.2185220","article-title":"Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases","volume":"20","author":"Carneiro","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115023_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114539","article-title":"Understanding excipient interactions unlocks untapped potential of RNA-lipid nanoparticles in dry powder formulations for local pulmonary delivery","volume":"390","author":"Martini","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115023_bb0885","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1021\/acs.molpharmaceut.5c00248","article-title":"Lipid nanoparticles-mediated mRNA delivery to the eye affected by ionizable cationic lipid","volume":"22","author":"Dong","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115023_bb0890","doi-asserted-by":"crossref","first-page":"8522","DOI":"10.1038\/s41467-025-63553-5","article-title":"Ocular delivery of lipid nanoparticles-formulated mRNA encoding lanosterol synthase ameliorates cataract in rats","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115023_bb0895","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jconrel.2025.01.068","article-title":"Lipid nanoparticle-mediated intracameral mRNA delivery facilitates gene expression and editing in the anterior chamber of the eye","volume":"379","author":"Vasudevan","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115023_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102609","article-title":"MicroRNA-responsive ON-OFF hybrid mRNA switch for precise protein expression control","volume":"36","author":"Masaki","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.115023_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102651","article-title":"From binary to synergy in precision mRNA therapeutics: dual-microRNA-sensing mRNAs for modular logic control of protein expression","volume":"36","author":"Tan","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.115023_bb0910","doi-asserted-by":"crossref","first-page":"2502346","DOI":"10.1080\/10717544.2025.2502346","article-title":"Light-triggered nanocarriers for nucleic acid delivery","volume":"32","author":"Huang","year":"2025","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115023_bb0915","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2025.1591119","article-title":"Enhancing nucleic acid delivery by the integration of artificial intelligence into lipid nanoparticle formulation","volume":"7","author":"Amoako","year":"2025","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0920","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41587-024-02490-y","article-title":"Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy","volume":"43","author":"Witten","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0925","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1038\/s41467-024-50619-z","article-title":"AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115023_bb0930","article-title":"Rational design of lipid nanoparticles for enhanced mRNA vaccine delivery via machine learning","volume":"21","author":"Bae","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115023_bb0935","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41565-025-01975-4","article-title":"Designing lipid nanoparticles using a transformer-based neural network","volume":"20","author":"Chan","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0940","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1038\/s41467-024-55072-6","article-title":"Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115023_bb0945","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcis.2024.06.158","article-title":"The vast majority of nucleic acid-loaded lipid nanoparticles contain cargo","volume":"674","author":"M\u00fcnter","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2026.115023_bb0950","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/s41598-024-52685-1","article-title":"A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient","volume":"14","author":"Schober","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115023_bb0955","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41587-024-02437-3","article-title":"Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR\u2013Cas9 ribonucleoprotein","volume":"43","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0960","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","article-title":"A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing","volume":"22","author":"Finn","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.115023_bb0965","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2426094122","article-title":"A general genome editing strategy using CRISPR lipid nanoparticle spherical nucleic acids","volume":"122","author":"Han","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115023_bb0970","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jconrel.2023.02.008","article-title":"Lipid nanoparticle-based ribonucleoprotein delivery for in vivo genome editing","volume":"355","author":"Onuma","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115023_bb0975","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s42003-022-03021-8","article-title":"Transfected plasmid DNA is incorporated into the nucleus via nuclear envelope reformation at telophase","volume":"5","author":"Haraguchi","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2026.115023_bb0980","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1006\/mthe.2002.0581","article-title":"The effect of cell division on the cellular dynamics of microinjected DNA and dextran","volume":"5","author":"Ludtke","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115023_bb0985","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1021\/mp200604h","article-title":"Comparison of the gene transfer efficiency of mRNA\/GL67 and pDNA\/GL67 complexes in respiratory cells","volume":"9","author":"Andries","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115023_bb0990","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010213","article-title":"Impact of formulation conditions on lipid nanoparticle characteristics and functional delivery of CRISPR RNP for gene knock-out and correction","volume":"14","author":"Walther","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115023_bb0995","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:22:36Z","timestamp":1783048956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":199,"alternative-id":["S0168365926004268"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115023","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovative lipid nanoparticle formulations: Bridging the gap toward decentralized personalized gene therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115023"}}